Blue Zone Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.97M | Buy |
12,248
+858
| +8% | +$348K | 1.24% | 43 |
|
|
2025
Q1 | $5.67M | Buy |
11,390
+1,264
| +12% | +$629K | 1.57% | 27 |
|
|
2024
Q4 | $5.27M | Buy |
10,126
+225
| +2% | +$117K | 1.52% | 25 |
|
|
2024
Q3 | $6.12M | Buy |
9,901
+436
| +5% | +$270K | 1.91% | 19 |
|
|
2024
Q2 | $5.23M | Sell |
9,465
-186
| -2% | -$103K | 1.81% | 18 |
|
|
2024
Q1 | $5.61M | Buy |
9,651
+198
| +2% | +$115K | 1.93% | 17 |
|
|
2023
Q4 | $5.02M | Buy |
9,453
+222
| +2% | +$118K | 2% | 17 |
|
|
2023
Q3 | $4.67M | Buy |
9,231
+143
| +2% | +$72.4K | 2.05% | 18 |
|
|
2023
Q2 | $4.74M | Buy |
9,088
+2,368
| +35% | +$1.24M | 2.19% | 16 |
|
|
2023
Q1 | $3.87M | Sell |
6,720
-4
| -0.1% | -$2.31K | 2.07% | 15 |
|
|
2022
Q4 | $3.7M | Buy |
6,724
+100
| +2% | +$55.1K | 1.98% | 14 |
|
|
2022
Q3 | $3.36M | Buy |
6,624
+36
| +0.5% | +$18.3K | 1.74% | 16 |
|
|
2022
Q2 | $3.58M | Buy |
6,588
+32
| +0.5% | +$17.4K | 1.62% | 17 |
|
|
2022
Q1 | $3.87M | Buy |
6,556
+1,267
| +24% | +$748K | 1.44% | 26 |
|
|
2021
Q4 | $3.53M | Sell |
5,289
-3
| -0.1% | -$2K | 1.17% | 30 |
|
|
2021
Q3 | $3.02M | Buy |
5,292
+40
| +0.8% | +$22.9K | 1.05% | 33 |
|
|
2021
Q2 | $2.65M | Buy |
5,252
+744
| +17% | +$375K | 0.99% | 43 |
|
|
2021
Q1 | $2.06M | Buy |
+4,508
| New | +$2.06M | 0.88% | 49 |
|